Related Experiment Video

Updated: Apr 21, 2026

A Hypoxia-reoxygenation Injury Model in Self-assembling Human Cardioids
09:41

A Hypoxia-reoxygenation Injury Model in Self-assembling Human Cardioids

Published on: March 17, 2026

181

Heme oxygenase-1: an emerging therapeutic target to curb cardiac pathology

Gabor Czibik1, Geneviéve Derumeaux, Daigo Sawaki

  • 1INSERM U955, Equipe 8, Faculty of Medicine, DHU A-TVB, Hôpital Henri Mondor, APHP, Creteil, University of Paris-Est, 3rd Floor, room 3006, Paris, France, gaborczibik@yahoo.com.

Basic Research in Cardiology
|October 26, 2014
PubMed

Insights

Heme oxygenase-1 (HO-1) activation offers protective effects against cardiovascular disorders by degrading heme. However, its role in cardiac remodeling due to pressure overload and diabetes requires further investigation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Heme oxygenase-1 (HO-1) is a stress-responsive enzyme degrading heme into protective molecules like carbon monoxide (CO).
  • HO-1 and its products (CO, bilirubin) are known for antioxidant, anti-inflammatory, and antihypertensive effects.
  • Emerging evidence suggests HO-1 may have antiproliferative and angiogenic roles.

Purpose of the Study:

  • To review the multifaceted roles of HO-1 and its products in cellular stress responses.
  • To critically evaluate the protective versus detrimental effects of HO-1 in cardiovascular diseases, particularly cardiac remodeling.
  • To highlight the need for further research into HO-1 regulation and therapeutic potential.

Main Methods:

  • Literature review and synthesis of recent findings on HO-1.
  • Analysis of HO-1's role in ischemia-reperfusion injury, hypertension, and cardiac remodeling.
  • Discussion of emerging regulatory mechanisms and therapeutic implications.

Main Results:

  • HO-1 activation confers protection against ischemia-induced injury and possesses acute antihypertensive effects.
  • Recent studies challenge the long-held view of HO-1's protective role in cardiac remodeling associated with pressure overload and type 2 diabetes.
  • The dual role of HO-1 necessitates a nuanced understanding of its function in different pathological contexts.

Conclusions:

  • HO-1 exhibits complex and context-dependent effects in cardiovascular physiology and pathology.
  • Further research is crucial to elucidate the intricate regulatory networks of HO-1.
  • Harnessing HO-1's therapeutic potential requires a deeper understanding for treating prevalent cardiovascular disorders.

More Related Videos

Bioluminescence Imaging of Heme Oxygenase-1 Upregulation in the Gua Sha Procedure06:39

Bioluminescence Imaging of Heme Oxygenase-1 Upregulation in the Gua Sha Procedure

Published on: August 28, 2009

13.1K
Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
742
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
803
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
885
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
930
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
606